Mixed Victory For Pfizer In Dutch Lipitor Battle

Law360, New York (September 13, 2006, 12:00 AM EDT) -- Pharmaceutical giant Pfizer Inc. has received another victory in its battle to protect Lipitor from generic reproduction, after a Dutch court ruled Ranbaxy Laboratories Ltd.’s version of the cholesterol drug would violate a Pfizer patent.

Pfizer said in a statement Wednesday that the District Court of The Hague in the Netherlands ruled that the basic patent for Lipitor would be infringed by Ranbaxy’s product. A second patent, however, was struck down.

The decision from the court’s three-judge panel prevents India-based Ranbaxy from launching a Dutch version...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.